The latest research & treatment news about Hepatitis C infection, diagnosis, symptoms and treatment.
Schering-Plough's lead Hepatitis C protease inhibitor has finished enrollment in a pivotal Phase III study. The completion of this study in 2010 could lead to boceprevir being approved for Hepatitis C treatment.
Continue reading »Because lymph problems abound in people with Hepatitis C, those with the virus have every reason to make their lymphatic health a priority. Discover four helpful suggestions for encouraging lymphatic circulation - by practicing them, maintaining lymphatic health is within anyone's reach.
Continue reading »Conquering viral hepatitis is hard enough without the added challenge of alcoholism. The drug gabapentin as a treatment for alcohol dependence is currently being evaluated in human trials.
Continue reading »Inspired by a pharmaceutical prototype to stop bovine viral diarrhea virus, Immtech reveals that one of their compounds may inhibit Hepatitis C's entry into human cells.
Continue reading »New research was presented at the American Association for Cancer Research supporting the use of Lapatinib for those with advanced liver cancer. Although currently approved for treating breast cancer, this drug represents hope for those who have progressed from chronic Hepatitis C to hepatocellular carcinoma.
Continue reading »A May 2005 review of clinical studies which casts doubt on milk thistle’s value has recently been re-released into the... View Article
Continue reading »It always does my heart well when more information is getting out there to the general public about Hepatitis c.
Continue reading »Are you confused about what viral load actually indicates regarding Hepatitis C? One of the most common misconceptions among Hepatitis... View Article
Continue reading »Inside you'll discover:
You'll also receive the latest news and information to support liver health.
Rest assured, we will not rent your email to anyone.
You should receive your email with links to the reports shortly. If you do not, please check your spam/junk folder.
If you still haven't received our email after a few minutes, please feel free to contact us.
Close Window
